title: Informed use of bedaquiline for tuberculosis.
authors.affiliation: Treatment Action Group, New York, NY 10016-7701, USA. Electronic address: erica.lessem@treatmentactiongroup.org.
authors.forename: Erica M
authors.initials: EM
authors.lastname: Lessem
authors.affiliation: Boston University School of Medicine, Boston, MA, USA; National Tuberculosis Controllers Association, Smyrna, GA, USA.
authors.forename: John
authors.initials: J
authors.lastname: Bernardo
authors.affiliation: Olive View-UCLA Medical Center Inpatient Tuberculosis Unit, Division of Infectious Diseases, Department of Medicine and David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
authors.forename: Caitlin
authors.initials: C
authors.lastname: Reed
authors.affiliation: National Tuberculosis Controllers Association, Smyrna, GA, USA.
authors.forename: Donna H
authors.initials: DH
authors.lastname: Wegener
mesh_terms: D064687:Diarylquinolines / Q000008:administration & dosage*; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D064687:Diarylquinolines